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Activation of the Lck Tyrosine Kinase
Targets Cell Surface T Cell Antigen Receptors
for Lysosomal Degradation
and necessary step in TCR-mediated signaling, leading
to complete T cell activation (Samelson and Klausner,
1992; Weiss, 1993).
Expression of the TCR on the cell surface is tightly
regulated during ontogeny. Cell surface TCR levels on
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CD41CD81 thymocytes are low and increase dramati-Bethesda, Maryland 20892±1152
cally when thymocytes undergo positive selection or are²Laboratory of Immunology
removed from the intact organ and placed in suspensionDivision of Hematologic Products
culture at 378C (Roehm et al., 1984). Several lines ofCenter for Biologics Evaluation and Research
evidence suggest that increased TCR expression resultsFood and Drug Administration
from down-regulation of Lck activity. First, injecting anti-Bethesda, Maryland 20852
CD4 antibodies in vivo or culturing thymocytes in sus-
pension at 378C, both of which disrupt CD4/MHC class
II molecule interactions and decrease CD4-associatedSummary
Lck activity (Wiest et al., 1993), results in TCR up-regula-
tion on CD41CD81 thymocytes (McCarthy et al., 1988).The mechanism by which TCR expression is regulated
Second, activation of CD4-associated Lck in culturedwas explored by expressing a constitutively active
CD41CD81 thymocytes prevents TCR up-regulation, anform of the tyrosine kinase Lck (Lck505F) in T cells.
inhibition that is reversed by tyrosine kinase inhibitorsExpression of Lck505F down-regulated TCR levels, an
(Wiest et al., 1993). Third, CD41CD81 thymocytes fromeffect that was even more pronounced in CD452 T
MHC class II and Lck knockout mice have high basalcells, in which the activity of this tyrosine kinase is
levels of cell surface TCRs (Gosgrove et al., 1991; Molinafurther enhanced. Cells expressing Lck505F synthesized
et al., 1992).all TCR subunits, but lysosomal degradation of assem-
Cell surface TCR levels vary in mature peripheral Tbled receptors was enhanced. TCRs were rapidly in-
cells as a result of activation. In this case, occupancyternalized and degraded after removal of a tyrosine
of theTCR results in rapid and long-lasting down-regula-kinase inhibitor thathad permitted cell surface expres-
tion (Reinherz et al., 1982; Valitutti et al., 1995). It hassion. Finally, TCR levels on thymocytes were increased
been proposed that this down-regulation is a conse-by an Lck inhibitor, and activation- but not phorbol
quence of ªserial engagementº of multiple TCRs andester±induced internalization of TCRs on Jurkat cells
that the accumulation of many ligand-binding eventswas prevented by inhibition or loss of Lck. These stud-
results in T cell activation (Viola and Lanzavecchia,ies identify a regulated nonreceptor tyrosine kinase±
1996). TCR down-modulation has also been proposedmediated pathway for targeting cell surface receptors
to be responsible, at least in part, for unresponsivenessfor lysosomal degradation.
of T cells previously stimulated with anti-TCR antibodies
in vitro (Pantaleo et al., 1987) as well as for in vivo
tolerance induction in a self-reactive TCR transgenicIntroduction
mouse model (Schonrich et al., 1991). Although the
mechanism of TCR internalization in mature T cells hasT cell activation is initiated by T cell antigen receptor
not been identified, attention has focused on the protein(TCR) recognition of antigen peptides bound to major
kinase C (PKC)±mediated phosphorylation of CD3g onhistocompatibility complex (MHC)±encoded molecules.
serine residues. Endocytosis and the recycling of cellThe multichain TCR isa transmembrane protein typically
surface TCRs have been shown to occur only for thecomposed of a clonotypic disulfide-linked ab hetero-
CD3g-phosphorylated form of TCR (Krangel, 1987), anddimer, responsible for antigen/MHC recognition, that is
phosphorylation of a CD3g intracellular serine in thenoncovalently associated with invariant subunits, in-
context of a dileucine motif is critical for phorbol ester±cluding the CD3 complex (g, d, and e) and the disulfide-
induced down-regulation of cell surface TCRs (Dietrichlinked z±z homodimer (Ashwell and Klausner, 1990). The
et al., 1994). It is unlikely, however, that activation ofsynthesis and assembly of all of these TCR subunits are
PKC accounts for long-lasting TCR down-regulation,required for normal expression of the receptor on the
since it has been shown to enhance TCR internalizationplasma membrane. The signaling capacity of the TCR
and recycling but not degradation (Krangel, 1987).depends on the intracytoplasmic domains of the z and
In this article, we address the means by which cellCD3 chains (Frank et al., 1990), in particular the regions
surface TCR levels are regulated by transient or stableknown as immnunoreceptor tyrosine activating motifs
expression of a constitutively active form of Lck (Lck505F)(ITAMs). Each CD3 chain has one ITAM, and the z chain
in T cells. Activated Lck caused down-regulation of cellhas three ITAMs. Activation of the Lck tyrosine kinase
surface TCRs but not other cell surface molecules, anfollowed by phosphorylation of the ITAMs is an early
effect that was more pronounced in CD452 cells, in
which Lck505F is even more active than it is in CD451 cells.³Present address: I. N. T. ªG. Pascale,º Sperimental Oncology
Loss of expression was due to the rapid internalizationC-Immunology, via Semmola, 80131 Napoles, Italy.
of completely assembled cell surface TCRs and their§To whom correspondence should be addressed (e-mail: jda@
box-j.nih.gov). degradation in lysosomes. These results demonstrate a
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Figure 1. Transient Expression of Lck505F De-
creases TCR Surface Levels in CD45-N1 Cells
by a Kinase-Dependent Mechanism
N1 cells were transiently transfected by elec-
troporation with GFP alone or with different
forms of Myc-tagged Lck (D'Oro et al., 1996),
or with no DNA as a mock transfected control,
as indicated. After 16 hr the cells werestained
with PE-labeled anti-TCR antibody H57±597
and analyzed with a FACScan. Dead cells
were excluded from the analysis by propid-
ium iodine staining.
(A) The green fluorescence profile for each
transfection is shown. Markers were set for
GFP2 (R1-gated) and GFP1 (R2-gated) popu-
lations, and these subsets were analyzed for
TCR expression detected by PE.
(B) After electroporation, half of each sample
transfected with wild-type Lck or Lck505F was
treated with PP1 (20 mM).
novel pathway in which the activation of the Lck tyrosine increased phosphorylation of the positive regulatory
residue tyrosine 394 (D'Oro et al., 1996), had a very largekinase directs the internalization and destruction of the
TCR. (75% by mean fluorescence) reduction in surface TCR
staining compared to cells cotransfected with vector
alone. In contrast, Lck273E1505F, a catalytically inactiveResults
form of Lck (Levin et al., 1993), had no effect on TCR
levels. Immunoblotting of transient transfectants withTransient Expression of Activated Lck
Down-Regulates Cell Surface TCRs an anti-Myc peptide antibody revealed that the different
forms of Myc-tagged Lck are expressed at similar levelsTo determine directly whether Lck regulates cell surface
TCR expression, forms of Lck that differ in enzymatic (data not shown).
The importance of Lck kinase activity was addressedactivity were transiently expressed in N1 cells, a CD452
variant of the murine T cell line YAC-1 in which Lck further by using PP1 (Hanke et al., 1996), a specific
inhibitor of Src-family kinases (Figure 1B). There waskinase activity is elevated because of the loss of this
tyrosine phosphatase (Volarevic et al., 1992; D'Oro et al., loss of TCR expression on a substantial number of GFP1
N1 cells transfected with wild-type Lck. An even greater1996). Cells were cotransfected with a plasmidencoding
the green fluorescence protein (GFP) (Chalfie et al., number of N1 cells lost TCR expression when trans-
fected with the constitutively active Lck505F. Importantly,1994), allowing us to examine TCR expression on cells
that did (GFP1) or did not (GFP2) receive the plasmids TCR levels were returned toward baseline in both cases
by the Lck inhibitor PP1. Together, these results demon-(Figure 1). TCR levels on untransfected CD452 YAC-1
(N1) cells (GFP2, R1 gated) were identical in all groups, strate that the reduction in TCR levels caused by Lck
requires its tyrosine kinase activity and that increasedregardless of the form of Lck used. In contrast, cells
cotransfected with Lck505F, a constitutively active kinase Lck activity results ina greatereffect onTCR expression.
This effect was not limited to YAC-1 cells, since similar(Amrein and Sefton, 1988; Marth et al., 1988) whose
activity is further enhanced in CD452 cells because of results were obtained with CD452 variants of the human
Lck Activity Targets TCRs for Lysosomal Degradation
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Figure 2. Analysis of TCR Expression on T
Cells Stably Expressing Different Forms of
Lck
Stable clones of CD451 (WT) and CD452 (N1)
YAC-1 cells expressing equivalent amounts
of different forms of Myc-tagged Lck, as pre-
viously described (D'Oro et al., 1996), were
analyzed for TCR expression by staining with
FITC-labeled anti-TCR antibody (H57±597).
Shownfor each clone are the negative control
staining (dotted line) and the TCR expression
of cells cultured for 16 hr in medium alone
(lightface lines) or with the tyrosine kinase
inhibitors herbimycin A at 3 mM (A) or PP1 at
20 mM (B) (boldface lines).
T cell lines Jurkat (Koretzky et al., 1991) and HPB-ALL (Figure 3A) and [35S]methionine metabolic labeling and
immunoprecipitation of CD3e, CD3g, and CD3d (data not(Shiroo et al., 1992) (data not shown).
shown). Immunoprecipitation and immunoblotting with
anti-z serum (Figure 3B) demonstrated a small but repro-Specific Down-Regulation of Cell Surface TCRs
on T Cells Stably Expressing Active Lck ducible reduction in z in N1-Lck505F cells (third lane) com-
pared to N1-Lck192F cells (sixth lane). Moreover, no zStable clones of CD451 YAC-1 (wild-type) and N1 cells
that expressed different forms of Lck (D'Oro et al., 1996) was detected in anti-CD3 immunoprecipitates from N1-
Lck505F cells (Figure 3B, compare second and fifth lanes).were analyzed. Strikingly, all seven independent Lck505F-
expressing CD452 clones had little or noTCR expression Since z associates only with otherwise complete recep-
tors (Bonifacino et al., 1988), these results indicate thaton the cell surface (a representative clone is shown in
Figure 2). In contrast, all CD452 cells stably transfected at steady state these cells express few mature, assem-
bled TCRs. Even more striking was that anti-a immu-with wild-type Lck (data not shown) or Lck192F, which was
used as a control tyrosine-to-phenylalanine mutation noblotting of anti-TCR immunoprecipitates from Lck505F-
expressing cells revealed no ab dimers associated withbecause it has wild-type kinase activity (D'Oro et al.,
1996), had normal levels of cell surface TCRs (Figure 2), CD3 (Figure 3C, compare lanes 1 and 2), and no ab
dimers were detected after precipitation with anti-bas did CD452 clones expressing the inactive Lck394F1505F
(data not shown). TCRs were also present on CD451 (compare lanes 3 and 4) or anti-a (compare lanes 5 and
6). Furthermore, no free a was detected in the anti-aclones transfected with Lck505 but at an intermediate
level (Figure 2). immunoprecipitate.
This result was confirmed with an anti-a blot of totalTo determine the relationship between Lck activity
and TCR levels, the effect of tyrosine kinase inhibitors cellular lysates, which detected little ab dimer in
N1-Lck505F cells (Figure 3D, second lane) compared towas determined. The Src-family kinase inhibitor herbi-
mycinA (June et al., 1990) had no effect on cellsexpress- cells expressing wild-type Lck (first lane) and no free a
in either cell. The ability of this antibody to detect freeing wild-type Lck (data not shown) or Lck192F (Figure
2A). In contrast, herbimycin A restored TCR levels from a chains was demonstrated by the immunoblotting of
lysates from 21.2.2 cells (Figure 3D, third lane), a murineundetectable to normal in CD452 cells expressing
Lck505F. Identical results were obtained with PP1 (Figure T cell hybridoma that expresses a but not b. Treatment
with the tyrosine kinase inhibitor herbimycin A restored2B). It is noteworthy that the tyrosine kinase inhibitors
also increased the intermediateTCR levels on the CD451 normal ab dimers in the Lck505F-expressing cells (Figure
3E, third and fourth lanes) but had no affect on thecells expressing Lck505F to wild-type levels, demonstrat-
ing that it is the enzymatic activity of Lck, and not the amount of this dimer in N1 cells expressing wild-type
Lck (first and second lanes).absence of CD45 per se, that determines the fate of cell
surface TCRs. The effect of activated Lck was specific Since Northern blot analysis showed no deficiency in
a or b mRNA in N1-Lck505F (data not shown), we analyzedfor the TCR in that the expression of CD44, CD2, CD27,
and the glycosylphosphatidylinositol-anchored protein ab protein synthesis and fate by metabolic labeling and
pulse-chase methods (Figure 4). Similar amounts of abThy-1 was unaffected (data not shown).
dimers were formed in Lck192-expressing (TCR1) and
Lck505F-expressing (TCR2) cells. These dimers under-Activated Lck Causes Lysosomal
Degradation of the TCR went similar carbohydrate processing, as evidenced by
increases in molecular size during the chase. The la-The expression of the individual TCR subunits was de-
termined. Levels of the CD3components were compara- beled ab was long-lived in the N1-Lck192F cells, showing
stability for at least 6 hr. In contrast, ab was short-livedble in N1 cells expressing Lck505F (TCR2) and Lck192F
(TCR1), as judgedby immunoblotting for CD3e and CD3g in N1-Lck505F cells, rapidly disappearing after 2±3 hr of
Immunity
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Figure 3. Expression of TCR Subunits in N1-Lck505F Cells
(A) An antiserum that recognizes CD3e and CD3g (serum 125) was used to immunoblot normal serum (NS) and anti-CD3 (2C11) immunoprecipi-
tates from N1-Lck192F and N1-Lck505F cells after SDS-PAGE in reducing conditions. The immunoblots were developed with 125I-protein A.
(B) Anti-z (serum 551) immunoblot of normal serum (NS), anti-CD3, and anti-z immunoprecipitates from N1-Lck192F and N1-Lck505F cells after
SDS-PAGE in reducing conditions.
(C) Anti-TCRa monoclonal antibody (H28±710) immunoblot of anti-CD3, anti-TCRb, and anti-TCRa immunoprecipitates from N1-Lck192F (lanes
1, 3, and 5) and N1-Lck505F (lanes 2, 4, and 6) cells after SDS-PAGE in nonreducing conditions (H28 does not blot after reduction; Becker et
al., 1989).
(D) Anti-TCRa immunoblot of total lysates of N1-Lck, N1-Lck505F, and 21.2.2 cells after SDS-PAGE in nonreducing conditions.
(E) Anti-TCRa was used to immunoblot nonreducing SDS-PAGE gels of total lysates of N1-Lck and N1-Lck505F cultured for 18 hr in medium
alone or with herbimycin A (3 mM).
chase, indicative of enhanced degradation. While pro- Lck192F-expressing cells. In contrast, TCR levels on N1-
Lck505F cells began to decrease within 5 min of washingteasome inhibitors did not affect ab degradation (data
not shown), two inhibitors of lysosome function, NH4Cl out the tyrosine kinase inhibitor, and returned almost
completely to steady state within 15 min. Therefore,and monensin, prevented ab degradation in Lck505F-
expressing cells and restored ab to almost normal levels activated Lck reduces TCR surface levels by inducing
rapid internalization and lysosomal degradation of fully(Figure 5A). Although NH4Cl had no effect on the amount
of ab associated with CD3 in the N1-Lck192F cells (Figure assembled receptors after expression on the plasma
membrane.5B), it restored ab/CD3 association in N1-Lck505F cells.
Association of the z chain with the ab/CD3 complex was
also unaffected by NH4Cl in Lck192F-expressing cells but
Lck Is Required for Anti-CD3±Inducedwas restored in Lck505F-expressing cells, indicating that
Down-Regulation of Cell Surface TCRsfully assembled TCRs were being directed to lysosomes
The role of Lck in activation-induced down-regulation(Figure 5C). Furthermore, inhibition of lysosomal func-
of cell surface TCRs was evaluated in several ways.tion increased the amount of total z in Lck505F-expressing
First, TCR levels on Jurkat T cells can be rapidly down-cells (data not shown). Thus the reduced level of z in
regulated by either phorbol ester or anti-CD3 antibodies.these cells is also due to lysosomal degradation.
As shown in Figure 7A, the anti-CD3 antibody OKT3
caused a substantial reduction in TCR expression on
Jurkat T cells that was completely blocked by PP1.Cell Surface TCRs Are Rapidly Internalized
by Activated Lck Treatment with OKT3 also resulted in the degradation
of TCR-associated z, which was specifically blocked bySince all of the TCR chains were normally synthesized
and the receptor fully assembled in Lck505F-expressing the lysosomotrophic agents ammonium chloride and
monensin (data not shown). In contrast, phorbol myris-cells, it seemed possible that the complete TCR might
enter the lysosomal degradation pathway after expres- tate acetate (PMA)±induced down-regulation of cell sur-
face TCRs was not prevented by PP1, and if anythingsion on the plasma membrane. To test this, TCRs were
allowed to accumulate on the surface of N1-Lck505F cells was actually enhanced by inhibition of Lck activity (Fig-
ure 7B). Finally, OKT3 was unable to cause the down-by treatment with PP1. Once normal levels were achieved,
brefeldin A was added to prevent egress of newly syn- regulation of cell surface TCRs on the Lck-negative mu-
tant of Jurkat, JCaM1.6, although PMA-induced TCRthesized TCRs from the endoplasmic reticulum (ER);
PP1 was washed out; and TCR levels on cells cultured down-regulation proceeded normally (Figure 7C). There-
fore, Lck activity is required for ligation-, but not phorbolat 378C were followed over time (Figure 6). As expected,
PP1 treatment had no effect on TCR expression on ester±, induced TCR internalization.
Lck Activity Targets TCRs for Lysosomal Degradation
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Figure 5. TCR ab Dimer Is Rapidly Degraded in Lysosomes in
Lck505F-Expressing N1 Cells
(A) Anti-TCRa immunoblot of total lysates of N1-Lck192F cells and
N1-Lck505F cultured for 7 hr in medium alone and of N1-Lck505F cells
cultured with NH4Cl (20 mM), monensin (20 mM), or monensin (2 mM)
for 7 hr.
(B) Anti-TCRa and (C) anti-z immunoblots of nonreducing SDS-Figure 4. TCR ab Dimer Is Synthesized and Assembled in Lck505F-
PAGE gels of anti-CD3 immunoprecipitates from N1-Lck192F and N1-Expressing N1 Cells
Lck505F cells cultured for 8 or 17 hr, respectively, in medium alone
N1-Lck192F and N1-Lck505F cells were metabolically labeled for 30 min or with NH4Cl (20 mM).with Trans35S-label, chased for the indicated periods of time, and
immunoprecipitated with anti-TCRb antibody. The immunoprecipi-
tates were analyzed by two-dimensional diagonal SDS-PAGE in has received a great deal of attention. CD41CD81 thy-
which the first dimension is run in nonreducing (NR) conditions and mocytes express a low level of TCRs that increases
the second in reducing (R) conditions (Kappler et al., 1983). The approximately 10-fold as the cellsare positivelyselected
position of the ab dimer below the diagonal is indicated.
and progress to the mature CD41CD82 or CD42CD81
phenotype. A similar increase in TCR levels on CD41
CD81 thymocytes can be obtained experimentally byInhibition of Lck Activity Increases Cell Surface
TCR Expression on Immature Thymocytes culturing them in cell suspension at 378C (Roehm et al.,
1984) or by injecting anti-CD4 antibody in vivo (McCarthyTo determine whetherLck activity is required to maintain
the low levels of cell surface TCRs found on immature et al., 1988). Both of these treatments disrupt CD4/MHC
class II molecule interactions, an event that can de-thymocytes, thymi from fetal d17 mice were placed in
organ culture for 16 hr in the absence or presence of crease CD4-associated Lck activity, suggesting that ac-
tivation of the tyrosine kinase Lck is able to reducePP1 (Figure 8). Thymocytes cultured in medium had
the typical pattern of low-to-intermediate levels of cell TCR expression on CD41CD81 thymocytes (Wiest et al.,
1993). More evidence of a role for Lck in the regulationsurface TCRs. In contrast, thymocytes cultured in the
presence of PP1 stained brightly for cell surface TCRs, of TCR levels is that the expression of transgenic ab
TCRs on CD41CD81 thymocytes is reduced by micewith levels 5- to 10-fold higher than those found on
untreated thymocytes. Thus, as with N1-Lck505 cells, in- coexpression of transgenic Lck505F and is returned to
normal by treatment with herbimycin A (Ericsson andhibition of Lck activity caused the up-regulation of cell
surface TCR levels on immature thymocytes. Teh, 1995). In this study we have extended this work by
demonstrating that the low-to-intermediate TCR levels
on normal immature thymocytes are increased approxi-Discussion
mately 10-fold when Lck activity is inhibited by PP1.
Previous studies analyzing the up-regulation of cellBecause of its biological significance, the regulation of
cell surface TCR expression, particularly on thymocytes, surface TCRs on CD41CD81 thymocytes by placing
Immunity
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Figure 6. Activated Lck Induces Rapid Internalization of Cell Sur-
face TCRs
N1-Lck192F and N1-Lck505F cells were incubated with PP1 (50 mM)
for 16 hr to allow TCR accumulation at the cell surface; washed;
resuspended in medium in the presence of brefeldin A (5 mM); and
incubated at 378C for various periods of time before being analyzed
for TCR surface expression with FITC-labeled anti-TCRb antibody. Figure 7. Lck Is Required for Anti-CD3±, but Not Phorbol Ester±,
Dotted lines, unstained cells. N1-Lck505F cells were incubated in Induced Down-Regulation of TCRs on Jurkat T Cells
medium alone (Untreated) or PP1 and were analyzed 0, 5, and 15 Jurkat T cells were cultured in medium or PP1 (20 mM) for 30 min
min after PP1 was washed out. N1-Lck192F cells were incubated in at 378C and then stimulated for 1 hr at 378C with OKT3 ascites
medium alone or PP1 and were analyzed 0 and 60 min after PP1 (1:1000) (A) or PMA (100 ng/ml) (B).
was washed out. (C) JCaM1.6 cells were cultured in medium or stimulated with OKT3
ascites (1:1000) or PMA (100 ng/ml). All cells were analyzed for CD3
surface expression with OKT3 followed by PE-labeled goat anti-
mouse IgG serum. Dotted lines, unstained cells.them in suspension or blocking CD4 with antibodies
have shown that this phenotype was not due to in-
creases in transcription, translation, or assembly of the that this is the case. Regardless, it is possible that both
decreased receptor assembly and increased turnoverTCR chainsÐobservations that led to the hypothesis
that Lck prevents egress of the TCR from the ER by a contribute to the low cell surface TCR levels on CD41
CD81 thymocytes, although the dramatic increaseposttranslational mechanism (Bonifacino et al., 1990;
Wiest et al., 1993). In light of the results shown in the caused by inhibition of Lck activity argues that the latter
is likely to be the predominant mechanism. We are cur-current report, however, these data may be interpreted
to indicate that in CD41CD81 thymocytes the TCRs are rently conducting studies to determine the site of TCR
degradation in thymocytes.in fact transported to the cell surface and then rapidly
internalized and degraded in lysosomes. Although in a Mature thymocytes that have been positively selected
in the thymus express high levels of surface TCRs, asprevious study NH4Cl had noeffect on CD3d degradation
in CD41CD81 thymocytes (Bonifacino et al., 1990), the do mature peripheral T cells. When peripheral T cells
are stimulated by antigen, however, the TCR level iscells had been analyzed only after being placed in sus-
pension culture at 378C, a condition in which TCR ex- rapidly down-regulated (Reinherz et al., 1982), a phe-
nomenon that has been suggested to be due to serialpression increases, and thus Lck-dependent lysosomal
degradation would not be expected. Other studies have engagement of many TCRs by a relatively few peptide/
MHC complexes (Valitutti et al., 1995). Internalization ofdemonstrated that unpaired TCRa chains in CD41CD81
thymocytes are degraded from the ER, suggesting a TCRs from the cell surface can also be induced, as
for other types of surface receptors, by phorbol esterlimiting role for this subunit in receptor assembly (Kearse
et al., 1994; Kearse et al., 1995). However, a limiting role treatment. Phorbol ester±induced internalization has
been shown to be dependent on PKC-mediated phos-in assembly does not mean that a is limiting for cell
surface expression, and at this time there is no evidence phorylation of CD3g on serine 126 in the context of a
Lck Activity Targets TCRs for Lysosomal Degradation
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Figure 8. Up-Regulation of TCR Expression
on Thymocytes by Inhibition of Lck Activity
Fetal d17 thymi were cultured either in me-
dium alone (top, lightface line) or with PP1
(20 mM) (top, boldface line) for 16 hr in serum-
free medium. Single-cell suspensions were
analyzed for expression of TCRb (top) or CD4
and CD8 (bottom) by flow cytometry.
dileucine motif (Dietrich et al., 1994), and a recent report absence of Lck activity. In preliminary experiments, we
have found that antigen-induced down-regulation ofhas shown that the presence of the intracytoplasmic
region of CD3g or CD3d is necessary for anti-CD3 anti- TCRs on antigen-specific T cell clones is also prevented
by treatment with PP1 (data not shown). These resultsbody±induced TCR internalization (Luton et al., 1997).
It is doubtful, however, that activation of PKC accounts are consistent with the notion that activation-induced
increases in Lck activity and lysosomal degradation playfor long-lasting TCR down-regulation. Unlike activation-
induced internalization, TCR internalization in response a role in the loss of occupied TCRs from the surface of
mature T cells.to phorbol esters is followed by recycling of the recep-
tors to the cell membrane (Krangel, 1987). Moreover, The results in this report deomnstrate a mechanism
in which activated Lck causes internalization and lyso-depletion of PKC (Boyer et al., 1991) or treatment with
PKC inhibitors (Luton et al., 1997) does not affect ligand- somal degradation of assembled cell surface TCRs. This
was reflected at steady state by decreased levels of zinduced TCR modulation. We have also found that anti-
gen- or antibody-induced down-regulation of cell surface and almost absent levels of a, which is limiting in these
cells, as indicated by the failure to detect free a in YAC-1TCRs on antigen-specific T cell clones or on YAC-1 and
Jurkat T cells is not inhibited by depleting the cells of cells. The simplest explanation of our results is that Lck
hyperphosphorylates one or more of the TCR subunits,PKC, although that is sufficient to prevent phorbol ester-
induced internalization (data not shown). generating a signal for internalization and degradation.
Consistent with this, in preliminary experiments we haveA recent report has demonstrated that antigen stimu-
lation of an antigen-specific T cell clone results in TCR been able to detect hyperphosphorylated z and CD3e
in N1-Lck505F cells in which TCR degradation was pre-internalization and loss of total cellular z chain (Valitutti
et al., 1997). Notably, the loss of z was prevented by vented by NH4Cl. ITAM phosphorylation createsdocking
sites for theSrc homology domain 2±containing proteinsinhibitors of lysosomal degradation. In a subsequent
study (Salio et al., 1997), the authors found that the ZAP-70 (Isakov et al., 1995) and Syk, resulting in the
recruitment of Lck to the complex (Thome et al., 1995),internalization caused by superantigen was not pre-
vented by Lck inhibitors, leading them to conclude that and for the adaptor molecule GRB2, which has been
found to be associated with the internalized epidermalSrc family kinases were not involved in this process. In
contrast, we show that anti-CD3±induced down-regula- growth factor (EGF) receptor upon EGF-induced down-
regulation (Wang and Moran, 1996). It is also possibletion of cell surface TCRs on Jurkat absolutely requires
Lck activity, as judged by inhibition with PP1 and by the that Lck phosphorylates and activates other molecule(s)
that interact with and internalize the TCR. It is notewor-inability of OKT3 to cause down-regulation on an Lck-
negative Jurkat mutant. TCR down-regulation induced thy that the ITAM regions contain a tyrosine-based sort-
ing signal able to interact with a subunit of the AP-2by phorbol esters, on the other hand, proceeded in the
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Fetal Thymic Organ Cultureclathrin-associated protein complex (Ohno et al., 1995),
Fetal thymic organ cultures were performed in serum-free Nutri-and that a dileucine motif in CD3g and CD3d is responsi-
doma-SP medium (Boehringer Mannheim) supplemented with 20ble for lysosomal targeting of these chains when sepa-
mM HEPES, 100 mM nonessential amino acids, 1 mM sodium pyru-
rately expressed (Letourneur and Klausner, 1992). Re- vate, and 50 mM 2-mercaptoethanol. Fetal d17 thymi were cultured
cent reports have demonstrated the involvement of with 20 mM PP1 or dimethyl sulfoxide vehicle control on a Millipore
filter floating on a gelfoam sponge in organ culture medium for 16GTP-binding proteins in the endocytosis of surface mol-
hr. Cultures were carried out in 3 ml of medium in six-well plates.ecules via clathrin-coatedpits (Bucci et al., 1992; Damke
Individual thymi were harvested and single-cell suspensions wereet al., 1994), and for one of them, dynamin, an unequivo-
prepared for counting and analyzed for CD4, CD8, and TCRb bycal role in ligand-mediated EGF receptor down-regula-
flow cytometry. Anti-CD4-Quantum Red was purchased from Sigma
tion has been established (Vieira et al., 1996). Whatever Chemicals (St. Louis, MO). Anti-CD8-FITC and anti-TCRb were pur-
the target molecule(s), the tyrosine kinase activity of Lck chased from Pharmingen (San Diego, CA).
is absolutely required for this effect, suggesting that
an induced association of the TCR with one or more Immunoprecipitation and Immunoblotting
Cells were lysed in lysis buffer containing 50 mM Tris-HCl (pH 7.6),molecular effectors is likely to occur. Elucidation of this
300 mM NaCl, 0.5% Triton X-100, leupeptin, aprotinin, and phospha-molecular pathway will provide valuable insight into the
tase inhibitors (2 mM sodium orthovanadate, 0.4 mM EDTA, 10 mMdynamic regulationof expression of the TCR inparticular
sodium fluoride, 10 mM sodium pyrophosphate). Immunoprecipita-and of cell surface receptors in general.
tion was performed on postnuclear fractions for 2 hr at 48C with
protein A-Sepharose beads (Zymed, San Francisco, CA) precoated
with the indicated antibodies. The precipitated proteins or total cell
Experimental Procedures lysates were separated by SDS±polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred to nitrocellulose membranes. The
Cell Lines and Reagents membraneswere blocked with 5% milk in phosphate-bufferedsaline
The CD451 murine T cell YAC-1 (wild-type), its CD452 variant (N1), and immunoblotted with the indicated antibodies in 2.5% milk. The
and stable transfectants cells expressing various forms of Myc epi- H28 antibody was used as hybridoma supernatant at 1:4 dilution;
tope±tagged Lck have been described (Volarevic et al., 1992; D'Oro serum 125 was used at 1:100 dilution; and serum 551 was affinity
et al., 1996). 21.2.2 is a TCRb-negative variant of the 2B4.11 T cell purified and used at 1:70 dilution. Immunoblots were developed by
hybridoma (Sussman et al., 1988). Jurkat cells and the Lck-negative 125I-protein A and autoradiography.
mutant JCaM1.6 (Straus and Weiss, 1992) were the generous gift
of Arthur Weiss (University of California, San Francisco). Expression
Metabolic Labeling and Two-Dimensional Gel Analysisvectors for wild-type Lck, Lck192F, Lck505F, and Lck5051273 driven by the
After starvation for 1 hr in cysteine- and methionine-free medium,ubiquitin promoter were generated in our laboratory as described
2 3 108 cells were subjected to metabolic labeling for 30 min with(D'Oro et al., 1996). An expressionvector forGFP (Chalfie et al., 1994)
1 mCi/ml of Trans35S label (ICN), washed with phosphate-buffereddriven by the cytomegalovirus promoter (pGEFP-N1) was obtained
saline, resuspended in complete medium, and divided into equalfrom Clontech Laboratories (Palo Alto, CA). The anti-mouse TCR
aliquots; each aliquot was further incubated for the indicated peri-subunit antibodies used were: H57±597 (H57), anti-TCRb (Kubo et
ods of time, lysed with lysis buffer, and immunoprecipitated withal., 1989); H28±710 (H28), anti-TCRa (Becker et al., 1989); 2C11±145
anti-TCRb antibody. The immunoprecipitates were analyzed by two-(2C11), anti-CD3e (Leo et al., 1987); anti-CD3e and anti-CD3g (serum
dimensional diagonal SDS-PAGE, in which the first dimension is run125) (Bonifacino et al., 1989); and anti-z (serum 551) (Cenciarelli et
in nonreducing conditions and the second in reducing conditions,asal., 1992). The anti-human CD3 antibody OKT3 was used as ascites
described (Kappler et al., 1983). After treatment with a 35S enhancerfluid. The antibodies used for immunofluorescence were purchased
(Enlightning, NEN Research Products, Boston, MA), gels were ex-from Pharmigen (San Diego, CA) and were: fluorescein isothiocya-
posed for autoradiography.nate (FITC)±labeled anti-TCR (H57±597), phycoerythrin (PE)±labeled
anti-TCR (H57±597), anti-CD27 (LG.3A10), anti-CD44 (IM7), anti-CD2
(RM2±5), and biotinylated anti-Thy-1.2 (CD90.2). PE-labeled strep- Acknowledgments
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